Table 2.
BMD measurements by COLIA1 genotypes at baseline and follow-up
| Promoter -1997 G/T | Intron 1 Sp1 G/T | |||||||
|---|---|---|---|---|---|---|---|---|
| GG | GT | TT | P* | GG | GT | TT | P* | |
| Men | n = 1,663 | n = 494 | n = 37 | n = 1,484 | n = 655 | n = 55 | ||
| Femoral neck (g/cm2) | 0.92 ± 0.13 | 0.92 ± 0.14 | 0.90 ± 0.14 | 1.00 | 0.92 ± 0.14 | 0.92 ± 0.14 | 0.90 ± 0.12 | 0.45 |
| Lumbar spine (g/cm2) | 1.16 ± 0.19 | 1.17 ± 0.20 | 1.15 ± 0.22 | 0.96 | 1.17 ± 0.19 | 1.16 ± 0.20 | 1.16 ± 0.20 | 0.91 |
| Number | n = 668 | n = 233 | n = 16 | n = 606 | n = 293 | n = 18 | ||
| FN-BMD change (relative % of baseline year) | −0.46 ± 0.91 | −0.36 ± 0.93 | −0.38 ± 0.60 | 0.62 | −0.39 ± 0.93 | −0.56 ± 0.87 | −0.30 ± 0.82 | 0.01 |
| Women | n = 2,157 | n = 710 | n = 53 | n = 1,971 | n = 858 | n = 91 | ||
| Femoral neck (g/cm2) | 0.83 ± 0.14 | 0.84 ± 0.13 | 0.85 ± 0.13 | 0. 22 | 0.83 ± 0.13 | 0.82 ± 0.14 | 0.80 ± 0.14 | 0.09** |
| Lumbar spine (g/cm2) | 1.03 ± 0.18 | 1.04 ± 0.18 | 1.01 ± 0.18 | 0.69 | 1.04 ± 0.18 | 1.04 ± 0.19 | 1.01 ± 0.20 | 0.52 |
| Number | n = 820 | n = 298 | n = 24 | n = 773 | n = 340 | n = 29 | ||
| FN-BMD change (relative % of baseline year) | −0.84 ± 1.11 | −0.83 ± 1.01 | −0.78 ± 1.03 | 0.85 | −0.85 ± 1.08 | −0.80 ± 1.04 | −0.74 ± 1.49 | 0.55 |
Values are expressed as mean ± SD. Adjustments for age and BMI. Femoral neck (FN) BMD change was measured between second follow-up and baseline
*P for ANOVA. **For trend linear regression: P = 0.03